Clinical trial Recruiting at 1 site Interventional Ages 12 to 15

Effectiveness of School-Based Solution-Focused Brief Therapy for Academic and Behavioral Problems in Adolescents

Official title: Effectiveness of School-Based Solution Focused Brief Therapy for Academic and Behavioral Problems in Adolescents

Run by National University of Modern Languages · NCT07811648 · Data updated 2026-11-12

This study tests whether school-based Solution-Focused Brief Therapy helps 6th–8th graders with academic and behavioral challenges wash out sociale effects when delivered now versus waiting list.

Quick facts

Study typeInterventional
Ages12 Years to 15 Years
SexAll
Enrollment100 (estimated)
SponsorNational University of Modern Languages
Academic / other
Locations1 site (Islamabad, Federal)
StatusRecruiting
StartedSeptember 17, 2026
Main results expectedNovember 17, 2026
Study endsDecember 10, 2026
Registry record updatedSeptember 10, 2026
Trial IDNCT07811648 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents in grades 6–8 identified by teachers and peers as having academic and behavioral difficulties and who have provided student consent.

Probably not a fit

Some students may not experience noticeable improvements in academics or behavior despite participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, wait-list controlled trial examines the impact of school-based Solution-Focused Brief Therapy (SFBT) on academic functioning and behavior in adolescents. Eligible students in grades 6–8 who are identified by teachers and peers as having difficulties are randomly assigned to receive the intervention immediately or after a wait-list period. Outcomes are measured at baseline and after the intervention to determine whether SFBT can improve school performance and behavior. The intervention is delivered within the school setting by a structured SFBT program. The study is led by the National University of Modern Languages with collaboration from FD Schools Islamabad.

Why it matters

Potential benefit: If successful, students may show improved academic performance and fewer behavioral problems, which could translate to better classroom engagement and outcomes.

How similar studies have gone: Previous trials of school-based, brief therapeutic approaches have shown mixed results; this study tests a targeted Solution-Focused Brief Therapy approach in a real-world school setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
1. Adolescents enrolled in grades 6-8.
2. Identified through teacher and peer nominations as having academic and behavioral difficulties.
3. Student consent was obtained.

Where it's running

  • FD Schools Islamabad
    Islamabad, Federal, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Brief behavioral parent training for children with behavior problems

    This study tests a new, shorter parent training program to help families with children aged 2 to 12 who have behavior problems like aggression and hyperactivity, making it easier for them to get support compared to regular programs.

    Recruiting Accare · Groningen, Provincie Groningen · NCT05591820

  • CBITS for Pakistani teens: a school-based trauma program

    A school-based group therapy called CBITS is being tested to see if it helps Pakistani adolescents who have experienced trauma feel less distressed and function better.

    Recruiting National University of Modern Languages · Islamabad · NCT07768540

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.